Common supplements rival antibiotics for severe gum disease
Originally at sciencedaily.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
For periodontal practices and general dentists managing Stage III/IV periodontitis, omega-3 plus low-dose aspirin produced clinical outcomes equivalent to systemic antibiotics over one year, offering a potential non-antibiotic adjunct that could reduce resistance risk and alter standard protocols.
Key points
- Year-long study found 58% of severe gum-disease patients reached treatment goal with either regimen.
- Both omega-3 fatty acids combined with low-dose aspirin and conventional antibiotics achieved identical 58% success rates.
- Result suggests an alternative pharmacologic approach that may lower antibiotic exposure in periodontal therapy.
- Supports consideration of non-antibiotic adjuncts in cases where resistance concerns or patient contraindications to antibiotics exist.
Who should care
Read the original on ScienceDaily Dentistry
Full reporting and any paywall content live on sciencedaily.com. We summarize and score; we do not republish.
Related
- ·Research
From mouth to brain: linking periodontal and peri-implant dysbiosis to systemic
- ·Research
Herpes zoster ophthalmicus following endodontic treatment: a case report
- ·Research
Formulation-dependent hydrothermal degradation of ultratranslucent 5y-tzp zirconia
- ·Clinical
Sotalol: When “LOL” is no laughing matter